GlassScriptPhysician profile
Steven Reilly
NPI 1023174075
$2,655.80
in general payments reported to CMS, 2019-2025
9 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $952 · 2024: $1,073 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,535.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,237.33 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Gm Pharmaceuticals, INC. | $455.70 | 2022-2023 | Vanalice, Vanacof |
| Abbvie INC. | $405.68 | 2023-2025 | |
| Amgen INC. | $223.33 | 2024 | Repatha |
| Gilead Sciences, INC. | $121.57 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.73 | 2023 | Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.12 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.82 | 2025 | |
| Novo Nordisk INC | $15.52 | 2024 | Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.